464 related articles for article (PubMed ID: 25660181)
1. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression.
Hogaboam CM; Murray L; Martinez FJ
Proc Am Thorac Soc; 2012 Jul; 9(3):172-6. PubMed ID: 22802293
[TBL] [Abstract][Full Text] [Related]
3. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
5. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
6. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
7. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
[TBL] [Abstract][Full Text] [Related]
8. Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis.
Järvinen PM; Myllärniemi M; Liu H; Moore HM; Leppäranta O; Salmenkivi K; Koli K; Latonen L; Band AM; Laiho M
J Cell Physiol; 2012 Jun; 227(6):2605-12. PubMed ID: 21882188
[TBL] [Abstract][Full Text] [Related]
9. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
10. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
[TBL] [Abstract][Full Text] [Related]
12. TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.
Trujillo G; Meneghin A; Flaherty KR; Sholl LM; Myers JL; Kazerooni EA; Gross BH; Oak SR; Coelho AL; Evanoff H; Day E; Toews GB; Joshi AD; Schaller MA; Waters B; Jarai G; Westwick J; Kunkel SL; Martinez FJ; Hogaboam CM
Sci Transl Med; 2010 Nov; 2(57):57ra82. PubMed ID: 21068441
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.
Ebener S; Barnowski S; Wotzkow C; Marti TM; Lopez-Rodriguez E; Crestani B; Blank F; Schmid RA; Geiser T; Funke M
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L42-L55. PubMed ID: 27815256
[TBL] [Abstract][Full Text] [Related]
14. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation.
Meneghin A; Choi ES; Evanoff HL; Kunkel SL; Martinez FJ; Flaherty KR; Toews GB; Hogaboam CM
Histochem Cell Biol; 2008 Nov; 130(5):979-92. PubMed ID: 18633634
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
[TBL] [Abstract][Full Text] [Related]
16. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
[TBL] [Abstract][Full Text] [Related]
17. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β.
Kottmann RM; Kulkarni AA; Smolnycki KA; Lyda E; Dahanayake T; Salibi R; Honnons S; Jones C; Isern NG; Hu JZ; Nathan SD; Grant G; Phipps RP; Sime PJ
Am J Respir Crit Care Med; 2012 Oct; 186(8):740-51. PubMed ID: 22923663
[TBL] [Abstract][Full Text] [Related]
18. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]